TLDR: Christian Reber, CEO of Berlin-based startup Pitch, has announced his resignation and signaled a change in leadership and strategy for the company. Reber acknowledged the challenges faced by venture-backed companies and emphasized the need for a more sustainable and profitability-focused approach. This shift reflects a larger trend among European startups, which have seen a decline in foreign investment and are reevaluating their goals and values for the future. The decision highlights the company’s emphasis on sustainability, practical growth, and a more balanced approach to success.
Shakeup in Euro Startups: Pitch’s CEO Shakes Things Up
Latest from Blog
Antheia Secures $17M Investment
TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
GRO Biosciences Secures $603M in Series B Funding
TLDR: GRO Biosciences, a biotechnology company, raised $60.3M in Series B funding led by Atlas Venture and Access Biotechnology. The company plans to use the funds to advance its lead program for
Raising $250 Million: North Sky Capital’s Impact Secondaries Fund
TLDR: North Sky Capital raised $250 million for its impact secondaries fund, Clean Growth VI. The fund aims to generate strong private equity returns while creating positive environmental and social benefits. North
Aven Achieves Unicorn Status: Raises $142m in Series D
TLDR: Aven, a fintech company offering home equity-backed credit cards, reaches unicorn status with a US$142m Series D funding round led by Khosla Ventures and General Catalyst. Founded in 2019 by former
Cell BioEngines Secures $2M Funding from SOSV and NY Ventures
TLDR: Cell BioEngines, Inc. secures an additional $2 million in funding from SOSV and Empire State Development’s New York Ventures. The funding will support the company’s first multicenter clinical trial aimed at